Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI
IAVI -

Key takeaways: Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any...

Related Articles

Latest in News

More from IAVI | Vaccine Lassa fever Clinical trial Nigeria International AIDS Vaccine Initiative Lassa mammarenavirus